Impact metric99% growth in revenue since engagement
“I saw an opportunity to advance South Africa's role in the biotech industry by producing world-class coronary stents.”
- South Africa
- Health Care/Life Sciences
- Year selected
With his Cape Town-based company DISA Vascular, Greg develops and produces world-class coronary stents, the small medical devices responsible for helping to restore blood flow to the heart in cardiology procedures. DISA Vascular is the first South African company to gain CE (European) approval of a Class III medical device. Poised for growth, Greg and his team recently constructed a state-of-the-art manufacturing facility and sells in 15 countries.
Endeavor and DISA Vascular
In addition to global mentorship on strategy issues, Greg has received introductions to investors. Additional services include an INSEAD feasibility study and Cape Town roundtable sessions.
Greg has demonstrated commitment by leading Endeavor HR workshops.